🍂 Enjoy the Fall Season! 🍂
MindTheDesk

Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s

Business Archived • September 25, 2026 • 7 views
As Novo works to turn itself around, some analysts say Lilly has advantages that could help it maintain its position at the top of the obesity drug market. 
Source: CNBC Top | https://search.cnbc.com/rs/search/combinedcms/view.xml?partnerId=wrss01&id=100003114 - Read Original
"We build AI or anything ICST"

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"Cardamom Spices and more to satisfy the tastebuds 100g $14.94"